Scopus BioPharma Inc. (SCPS)
OTCMKTS: SCPS · Delayed Price · USD
0.0005
-0.0019 (-79.17%)
Mar 28, 2024, 1:43 PM EDT - Market closed

Scopus BioPharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Selling, General & Admin
9.0312.612.732.230.41
Research & Development
2.6815.027.420.460.28
Operating Expenses
11.7127.6310.162.690.69
Operating Income
-11.71-27.63-10.16-2.69-0.69
Interest Expense
00.770.7100
Other Expense / Income
--1.46---
Pretax Income
-11.71-26.95-10.86-2.69-0.69
Income Tax
-0.110.770.7100
Net Income
-11.61-27.73-11.57-2.69-0.69
Shares Outstanding (Basic)
2117131515
Shares Outstanding (Diluted)
2117131515
Shares Change
22.27%29.11%-10.77%--
EPS (Basic)
-0.55-1.61-0.87-0.18-0.05
EPS (Diluted)
-0.55-1.61-0.87-0.18-0.05
Free Cash Flow
-8.13-11.43-2.53-2.12-0.75
Free Cash Flow Per Share
-0.39-0.66-0.19-0.14-0.05
EBITDA
-11.71-27.63-10.15-2.69-0.69
Depreciation & Amortization
00000
EBIT
-11.71-27.63-10.16-2.69-
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.